Back to Results
First PageMeta Content
Dual-energy X-ray absorptiometry / Osteoporosis / Bone density / Peripheral quantitative computed tomography / Osteopenia / Alendronic acid / Human skeleton / Bisphosphonate / Hip fracture / Medicine / Radiology / Drugs


1248 Final decision analytic protocol (DAP) to guide the assessment of bone mineral density analyses using dual energy X-ray absorptiometry (DXA) or quantitative computerised tomography (QCT) for men and women aged 60 -
Add to Reading List

Document Date: 2014-10-28 21:29:41

Open Document

File Size: 323,37 KB

Share Result on Facebook

City

Baltimore / Canberra / London / /

Company

Norland Corp / Patient Total / Medical Systems Lunar GE Medical Systems Australia Pty Ltd / Dohme (Australia) Pty Ltd / N/A Resources / GE / MBS Resources / Inderlec Medical Systems Pty Ltd / Cytyc Australia Pty Ltd / Medilink Inderlec Medical Systems Pty Ltd / Capri Workshop Group / TBA Resources / Merck / Osteoporosis Australia / Medical Journal of Australia / Hologic Inc / Wilkins Company / /

Continent

Australia / North America / Europe / Americas / /

Country

United States / Australia / /

Currency

USD / /

Facility

National Institute of Arthritis / University of Sheffield / hospital Costs / Australian Institute of Health / Skin Diseases< National Institute of Health / /

IndustryTerm

anti-resorptive pharmaceutical / fracture risk assessment tools / fracture determinant tools / health services / treatment of osteoporosis / treatment for prostate cancer / draft protocol / clinical pathway algorithms / final protocol / decision analytic protocol / imaging / energy / computed tomography systems / health insurer / fracture risk tools / absorptiometry device / treatment of breast cancer / clinical management algorithm / healthcare resources / draft decision analytic protocol / dual-energy / diagnostic tool / /

MedicalCondition

arthritis / Female hypogonadism / Rheumatoid arthritis / chronic renal disease / muscle weakness / Primary hyperparathyroidism / malabsorbtive disorder / disorder / hypogonadism / renal disease / Bone resorption / Breast Cancer / osteopenia / malabsorptive disorders / osteoporosis DXA / disease / Chronic liver disease / Chronic / hypogonadism Primary hyperparathyroidism Chronic / Male hypogonadism / Diseases / osteoporosis / Primary hyperparathyroidism Chronic / metabolic bone disease / Skin Diseases / osteoporosis PASC / /

MedicalTreatment

Dietary supplements / hormone therapy / radiation / Endocrine Therapies / Drug therapies / /

Organization

National Institute of Health / World Health Organization / University of Sheffield / American Medical Association / National Institute of Arthritis and Musculoskeletal / Department of Health / Medical Services Advisory Committee / Pharmaceutical Benefits Pricing Authority / Australian Institute of Health / /

/

Position

general practitioner / Commonwealth Minister / physician / consultant physician / technician / Governor / Government Health Minister / absorptiometry device Technician / /

Product

alendronate sodium / Vitamin D / /

PublishedMedium

Elsevier / Clinical Medicine / /

Technology

radiation / X-ray / draft decision analytic protocol / tomography / antibodies / management algorithm / ultrasound / clinical pathway algorithms / apoptosis / draft protocol / X-ray system / Chemotherapy / clinical management algorithm / 1248 Final decision analytic protocol / final protocol / /

URL

http /

SocialTag